MORI Fumiaki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Assistant Professor
Language English
Title Maintenance Antithrombotic Therapy and Long-term Prognosis in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention -1 year Landmark Analysis-
Conference The 79th Annual Scientific Meeting of the Japanese Circulation Society
Promoters Japanese Circulation Society
Conference Type Nationwide Conferences
Presentation Type Speech
Lecture Type General
Publisher and common publisher◎TANIGAITO Yusuke, OOTSUKI Hisao, WATANABE Masahiro, KAMISHIMA Kazuho, NAKAO Masashi, OKAYAMA Dai, HARUKI Shintaro, JUJO Kentaro, ARASHI Hiroyuki, MINAMI Yuichiro, TAKAGI Atsushi, OOTA Yoshimi, TANAKA Hiroyuki, MORI Fumiaki, FUJII Shinya, HONDA Atsushi, YAMAGUCHI Junichi, HAGIWARA Nobuhisa
Date 2015/04/26
(city and name of the country)
Osaka, JAPAN
Society abstract PROGRAM JCS 2015 736
Summary The aim of this study was to assess the relationship between maintenance antithrombotic therapy after 1-year and clinical outcomes.Methods and Results: Consecutive 450 patients with atrial fibrillation undergoing percutaneous coronary intervention were enrolled at 8 medical centers. We examined 274 patients who had no adverse event during 1st year and could be followed more than 1-year (landmark point). At 1-year, triple therapy (TT; warfarin + dual anti-platelet therapy) was continued in 123 patients (45%), only 2 patients were on warfarin only. The incidence of major adverse cerebro-cardiovascular events (MACCE; cardiac death, non-fatal myocardial infarction, stroke) and bleeding complications were evaluated in four medical regimens. The results were shown below.Conclusion: Patients who continued TT over 1-year had similar incidence of MACCE but more bleeding complications, compared to other regimens.